GAMMA Investing »

Contineum Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-09-30 $549 41 13.41
2025-06-30 $238 60 3.97
2025-03-31 $1.3k 182 6.98
2024-12-31 $1.2k 80 14.65

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Micron Technology Common Stock (MU)
Eli Lilly Common Stock (LLY)
Advanced Micro Devices Common Stock (AMD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Tesla Common Stock (TSLA)

View all positions for GAMMA Investing

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Jupiter Topco
BlackRock
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Vanguard Capital Management
Perceptive Advisors
FMR
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Ikarian Capital
Sectoral Asset Management
Geode Capital Management

View all funds holding Contineum Therapeutics